rs149563712
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4BS1_Supporting
The NM_012414.4(RAB3GAP2):c.1580C>T(p.Pro527Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000214 in 1,614,020 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P527R) has been classified as Uncertain significance.
Frequency
Consequence
NM_012414.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RAB3GAP2 | NM_012414.4 | c.1580C>T | p.Pro527Leu | missense_variant | 15/35 | ENST00000358951.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RAB3GAP2 | ENST00000358951.7 | c.1580C>T | p.Pro527Leu | missense_variant | 15/35 | 1 | NM_012414.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152138Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000334 AC: 84AN: 251330Hom.: 0 AF XY: 0.000324 AC XY: 44AN XY: 135824
GnomAD4 exome AF: 0.000215 AC: 314AN: 1461764Hom.: 1 Cov.: 31 AF XY: 0.000221 AC XY: 161AN XY: 727194
GnomAD4 genome AF: 0.000210 AC: 32AN: 152256Hom.: 0 Cov.: 31 AF XY: 0.000188 AC XY: 14AN XY: 74444
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 17, 2020 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 15, 2019 | - - |
Global developmental delay;C4551563:Microcephaly Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jul 17, 2019 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.1580C>T (p.P527L) alteration is located in exon 15 (coding exon 15) of the RAB3GAP2 gene. This alteration results from a C to T substitution at nucleotide position 1580, causing the proline (P) at amino acid position 527 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Amenorrhea Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Yale Center for Mendelian Genomics, Yale University | Mar 08, 2021 | - - |
Martsolf syndrome;C3280214:Warburg micro syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 527 of the RAB3GAP2 protein (p.Pro527Leu). This variant is present in population databases (rs149563712, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with RAB3GAP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 580491). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RAB3GAP2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
RAB3GAP2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 11, 2024 | The RAB3GAP2 c.1580C>T variant is predicted to result in the amino acid substitution p.Pro527Leu. This variant has been reported in a homozygous state in an individual with RAB3GAP2-related disorder (Akula SK et al 2023. PubMed ID: 37486637) and in an individual with hypothalamic amenorrhoea, although the zygosity is unknown (Delaney et al 2021. PubMed ID: 32870266). This variant is reported in 0.11% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at